White House chief medical advisor Dr. Anthony Fauci to step down in December after more than 50 years of public service

White House chief medical advisor Dr. Anthony Fauci to step down in December after more than 50 years of public service


Dr. Anthony Fauci speaks about the Omicron coronavirus variant during a press briefing at the White House in Washington, December 1, 2021.

Kevin Lamarque | Reuters

The nation’s top infectious disease expert, Dr. Anthony Fauci, plans to step down from his roles running the National Institute of Allergy and Infectious Diseases and advising the White House as its chief medical advisor at the end of the year, he announced Monday.

Fauci has become a household fixture during the Covid-19 pandemic, battling back misinformation — sometimes from the highest levels of government. His steadfast commitment to science, challenging former President Donald Trump on everything from the use of  hydroxychloroquine to mask mandates, made him a quasi-celebrity in the process.

The 81-year-old has advised seven U.S. presidents, starting with Ronald Reagan through the HIV/AIDS epidemic, West Nile virus, the 2001 anthrax attacks, pandemic influenza, various bird influenza threats, Ebola, Zika and, most recently, Covid and monkeypox.

Fauci, who also runs the NIAID Laboratory of Immunoregulation, said he has no intentions of retiring.

“After more than 50 years of government service, I plan to pursue the next phase of my career while I still have so much energy and passion for my field,” Fauci said in a statement. “I want to use what I have learned as NIAID Director to continue to advance science and public health and to inspire and mentor the next generation of scientific leaders as they help prepare the world to face future infectious disease threats.”

He first joined the National Institutes of Health in 1968 at age 27 where he quickly rose through the ranks and eventually took over as director of the National Institute of Allergy and Infectious Diseases in 1984.

Fauci didn’t shy away from conflict. His Senate hearings were often peppered with terse exchanges with members of Congress, particularly with Sen. Rand Paul, R-Ky., who he once accused of inciting death threats against him and his family.

“What happens when he gets out and accuses me of things that are completely untrue is that all of a sudden that kindles the crazies out there and I have threats upon my life, harassment of my family and my children with obscene phone calls, because people are lying about me,” Fauci told the Senate health committee at a January hearing.

This is breaking news. Please check back for updates.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More